Total Payments
$3,776
2024 Payments
$553.46
Companies
19
Transactions
183
Medicare Patients
1,383
Medicare Billing
$85,451
Payment Breakdown by Category
Food & Beverage$3,606 (95.5%)
Education$169.98 (4.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,606 | 181 | 95.5% |
| Education | $169.98 | 2 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $823.24 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $464.45 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $349.06 | 13 | $0 (2024) |
| LEO Pharma Inc. | $283.11 | 14 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $273.09 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $272.34 | 12 | $0 (2023) |
| UCB, Inc. | $258.13 | 15 | $0 (2023) |
| Incyte Corporation | $242.20 | 10 | $0 (2023) |
| GENZYME CORPORATION | $208.16 | 9 | $0 (2024) |
| Lilly USA, LLC | $201.72 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $553.46 | 27 | Amgen Inc. ($138.68) |
| 2023 | $646.10 | 26 | Incyte Corporation ($161.34) |
| 2022 | $1,261 | 58 | ABBVIE INC. ($400.47) |
| 2021 | $1,316 | 72 | AbbVie Inc. ($314.01) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Immunology | ||||||
| 10/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: Inflammation | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Inflammation | ||||||
| 07/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Inflammation | ||||||
| 05/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: Inflammation | ||||||
| 05/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Oncology | ||||||
| 04/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Inflammation | ||||||
| 04/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: Inflammation | ||||||
| 04/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: IMMUNOLOGY | ||||||
| 03/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 03/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Inflammation | ||||||
| 02/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Inflammation | ||||||
| 02/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 619 | 1,185 | $124,492 | $34,912 |
| 2022 | 11 | 723 | 1,199 | $134,365 | $49,236 |
| 2020 | 3 | 41 | 45 | $8,214 | $1,303 |
Total Patients
1,383
Total Services
2,429
Medicare Billing
$85,451
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 64 | 81 | $21,465 | $7,505 | 35.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 108 | 140 | $35,000 | $7,363 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 132 | $16,968 | $5,960 | 35.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 35 | 38 | $7,910 | $2,627 | 33.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 52 | 76 | $5,320 | $2,496 | 46.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 70 | 83 | $9,960 | $2,185 | 21.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 66 | 505 | $7,575 | $2,150 | 28.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 53 | 62 | $7,110 | $1,841 | 25.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $7,289 | $1,477 | 20.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 16 | 19 | $4,465 | $1,007 | 22.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,430 | $301.62 | 21.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 66 | 80 | $21,200 | $9,148 | 43.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 107 | 127 | $31,750 | $7,921 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 120 | $15,000 | $7,382 | 49.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 74 | 87 | $17,835 | $6,680 | 37.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 83 | 83 | $15,355 | $5,737 | 37.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 69 | 79 | $6,320 | $3,051 | 48.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 68 | 75 | $9,000 | $2,263 | 25.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 65 | 455 | $6,825 | $2,198 | 32.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 22 | 22 | $4,070 | $1,926 | 47.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 34 | 34 | $4,420 | $1,603 | 36.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 33 | 37 | $2,590 | $1,327 | 51.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 22 | $3,212 | $615.64 | 19.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 11 | 11 | $2,398 | $393.20 | 16.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $2,604 | $294.12 | 11.3% |
About Cyrus Querol, P.A
Cyrus Querol, P.A is a Physician Assistant healthcare provider based in Pomona, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1013365923.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cyrus Querol, P.A has received a total of $3,776 in payments from pharmaceutical and medical device companies, with $553.46 received in 2024. These payments were reported across 183 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,606).
As a Medicare-enrolled provider, Querol has provided services to 1,383 Medicare beneficiaries, totaling 2,429 services with total Medicare billing of $85,451. Data is available for 3 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location Pomona, CA
- Active Since 06/01/2016
- Last Updated 06/01/2016
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013365923
Products in Payments
- DUPIXENT (Biological) $505.52
- SKYRIZI (Biological) $442.42
- HUMIRA (Biological) $328.80
- COSENTYX (Biological) $290.78
- Cimzia (Drug) $258.13
- ENSTILAR (Drug) $216.48
- TALTZ (Drug) $186.32
- REMICADE (Biological) $180.90
- OPZELURA (Drug) $172.21
- TREMFYA (Drug) $168.16
- Otezla (Drug) $161.49
- COSENTYX (Drug) $127.35
- Winlevi (Drug) $120.90
- SPEVIGO (Drug) $85.52
- ADBRY (Biological) $66.63
- Ilumya (Biological) $41.99
- ILUMYA (Biological) $31.76
- Absorica LD (Drug) $30.18
- RINVOQ (Biological) $29.28
- BLU-U (Medical Supply) $25.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Pomona
Mr. Jeffrey Steed, Pa-C, PA-C
Physician Assistant — Payments: $19,785
Physician Assistant $19,785
Brittney Tunon
Physician Assistant — Payments: $5,832
Physician Assistant $5,832
David Cao
Physician Assistant — Payments: $5,504
Physician Assistant $5,504
Hung Dinh, Pa, PA
Physician Assistant — Payments: $5,468
Physician Assistant $5,468
Miss. Hailey Garrison
Physician Assistant — Payments: $5,107
Physician Assistant $5,107
Mrs. Vanessa Pedrego, Pa-C, PA-C
Physician Assistant — Payments: $5,062
Physician Assistant $5,062